JANSSEN-CILAG has partnered with Sigma Healthcare to roll out a new support program for patients taking Simponi (golimumab) for rheumatic disease.
The program aims to ensure patients are provided with quality medication advice and ongoing support in adherence, with the aim of achieving optimal health outcomes.
Pharmacists participating in the program must undertake prerequisite online education modules, with payments to the pharmacy for completion as well as for initial and subsequent patient consultations.
For details see page four.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Mar 19
